NO942303L - - Google Patents
Info
- Publication number
- NO942303L NO942303L NO942303A NO942303A NO942303L NO 942303 L NO942303 L NO 942303L NO 942303 A NO942303 A NO 942303A NO 942303 A NO942303 A NO 942303A NO 942303 L NO942303 L NO 942303L
- Authority
- NO
- Norway
- Prior art keywords
- inhibitor
- active ingredient
- preparations
- mao
- uptake
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU914060A HUT63579A (en) | 1991-12-20 | 1991-12-20 | Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes |
PCT/HU1992/000060 WO1993012775A1 (en) | 1991-12-20 | 1992-12-18 | Pharmaceutical composition and process for the preparation thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
NO942303D0 NO942303D0 (no) | 1994-06-17 |
NO942303L true NO942303L (hu) | 1994-08-17 |
Family
ID=10966728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO942303A NO942303D0 (no) | 1991-12-20 | 1994-06-17 | Farmasöytisk preparat, samt fremgangsmåte for fremstilling derav |
Country Status (27)
Country | Link |
---|---|
US (1) | US5589513A (hu) |
EP (1) | EP0617615A1 (hu) |
JP (1) | JPH07502730A (hu) |
KR (1) | KR940703655A (hu) |
AU (1) | AU677170B2 (hu) |
BG (1) | BG98827A (hu) |
BR (1) | BR9206950A (hu) |
CA (1) | CA2125776A1 (hu) |
CZ (1) | CZ147494A3 (hu) |
EC (1) | ECSP930933A (hu) |
EE (1) | EE03015B1 (hu) |
FI (1) | FI942932A0 (hu) |
HU (2) | HUT63579A (hu) |
IL (1) | IL104150A (hu) |
LT (1) | LT3119B (hu) |
LV (1) | LV10386B (hu) |
MY (1) | MY111055A (hu) |
NO (1) | NO942303D0 (hu) |
NZ (1) | NZ246384A (hu) |
PH (1) | PH31073A (hu) |
PL (1) | PL172048B1 (hu) |
RO (1) | RO115785B1 (hu) |
RU (1) | RU2125448C1 (hu) |
SI (1) | SI9200404A (hu) |
SK (1) | SK74494A3 (hu) |
WO (1) | WO1993012775A1 (hu) |
ZA (1) | ZA929883B (hu) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5844003A (en) * | 1991-04-04 | 1998-12-01 | Innovations Foundation | Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function |
US5817336A (en) * | 1993-04-02 | 1998-10-06 | Orion-Yhtyma Oy | Composition containing selegiline |
DE4432610C1 (de) * | 1994-09-13 | 1996-02-01 | Knoll Ag | Verfahren zur Herstellung von Selegilin-Hydrochlorid |
EP0808160A1 (en) | 1995-02-10 | 1997-11-26 | The University Of Toronto Innovations Foundation | Deprenyl compounds for treatment of glaucoma |
JP4499208B2 (ja) | 1998-10-29 | 2010-07-07 | 株式会社フジモト・コーポレーション | 新規な光学活性アミノペンタン誘導体 |
US7374779B2 (en) * | 1999-02-26 | 2008-05-20 | Lipocine, Inc. | Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
HUP9902482A2 (hu) * | 1999-07-22 | 2002-04-29 | Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. | P-fluoro-selegilin alkalmazása neuroprotektív gyógyszerkészítmények előállítására |
EP2053033A1 (en) * | 2007-10-26 | 2009-04-29 | Bayer Schering Pharma AG | Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors |
US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
DE102009045056A1 (de) * | 2009-09-28 | 2011-03-31 | Henkel Ag & Co. Kgaa | Fleckenvorbehandlungsmittel |
US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
WO2016033549A2 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
WO2016033556A1 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS |
CA3078723A1 (en) | 2016-11-28 | 2018-05-31 | Nachiappan Chidambaram | Oral testosterone undecanoate therapy |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1227447B (de) * | 1962-03-30 | 1966-10-27 | Chinoin Gyogyszer Es Vegyeszet | Verfahren zur Herstellung von Phenylisopropylaminen |
HU193662B (en) * | 1983-12-20 | 1987-11-30 | Chinoin Gyogyszer Es Vegyeszet | Process for producing synergetic pharmaceutical composition of antidepressive aktivity |
HU207282B (en) * | 1984-05-31 | 1993-03-29 | Chinoin Gyogyszer Es Vegyeszet | Process for producing phenyl-alkyl-amine derivatives and pharmaceutical compositions containing them |
ATE55245T1 (de) * | 1986-04-16 | 1990-08-15 | Asta Pharma Ag | Synergistische kombination von amantadin und selegilin. |
HU207280B (en) * | 1986-09-25 | 1993-03-29 | Chinoin Gyogyszer Es Vegyeszet | Process for producing new phenyl-alkyl-amines and pharmaceutical compositions containing them |
HU197510B (en) * | 1986-12-19 | 1989-04-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing pharmaceutical composition containing phenyl-alkyl-amine derivatives, against motion-sick |
US4861800A (en) * | 1987-08-18 | 1989-08-29 | Buyske Donald A | Method for administering the drug deprenyl so as to minimize the danger of side effects |
GB8807504D0 (en) * | 1988-03-29 | 1988-05-05 | Sandoz Ltd | Improvements in/relating to organic compounds |
HU208484B (en) * | 1988-08-17 | 1993-11-29 | Chinoin Gyogyszer Es Vegyeszet | Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia |
CA2037178A1 (en) * | 1990-02-28 | 1991-08-29 | Albert Walter Brzeczko | Deprenyl/l-dopa/carbidopa pharmaceutical composition |
GB9011767D0 (en) * | 1990-05-25 | 1990-07-18 | Britannia Pharmaceuticals Ltd | Pharmaceutical compositions |
US5169868A (en) * | 1991-03-01 | 1992-12-08 | University Of Saskatchewan | Aliphatic propargylamines as specific mao-b inhibitors |
US5444095A (en) * | 1991-04-04 | 1995-08-22 | University Of Toronto, Innovations Foundation | Use of deprenyl to rescue damaged nerve cells |
HU209605B (en) * | 1991-04-15 | 1994-09-28 | Chinoin Gyogyszer Es Vegyeszet | Process for production of wather-free transdermal preparation |
US5326770A (en) * | 1992-07-17 | 1994-07-05 | The Du Pont Merck Pharmaceutical Company | Monoamine oxidase-B (MAO-B) inhibitory 5-substituted 2,4-thiazolidinediones useful in treating memory disorders of mammals |
-
1991
- 1991-12-20 HU HU914060A patent/HUT63579A/hu unknown
-
1992
- 1992-12-18 SK SK744-94A patent/SK74494A3/sk unknown
- 1992-12-18 NZ NZ246384A patent/NZ246384A/en unknown
- 1992-12-18 MY MYPI92002341A patent/MY111055A/en unknown
- 1992-12-18 JP JP5510411A patent/JPH07502730A/ja active Pending
- 1992-12-18 SI SI9200404A patent/SI9200404A/sl unknown
- 1992-12-18 AU AU32652/93A patent/AU677170B2/en not_active Ceased
- 1992-12-18 PH PH45474A patent/PH31073A/en unknown
- 1992-12-18 CA CA002125776A patent/CA2125776A1/en not_active Abandoned
- 1992-12-18 BR BR9206950A patent/BR9206950A/pt not_active Application Discontinuation
- 1992-12-18 CZ CZ941474A patent/CZ147494A3/cs unknown
- 1992-12-18 IL IL104150A patent/IL104150A/xx not_active IP Right Cessation
- 1992-12-18 US US08/256,128 patent/US5589513A/en not_active Expired - Fee Related
- 1992-12-18 WO PCT/HU1992/000060 patent/WO1993012775A1/en not_active Application Discontinuation
- 1992-12-18 ZA ZA929883A patent/ZA929883B/xx unknown
- 1992-12-18 RO RO94-01015A patent/RO115785B1/ro unknown
- 1992-12-18 PL PL92304116A patent/PL172048B1/pl unknown
- 1992-12-18 EP EP93901880A patent/EP0617615A1/en not_active Withdrawn
- 1992-12-18 RU RU94031161A patent/RU2125448C1/ru active
- 1992-12-18 KR KR1019940702143A patent/KR940703655A/ko active IP Right Grant
- 1992-12-20 LV LVP-92-547A patent/LV10386B/en unknown
- 1992-12-21 LT LTIP249A patent/LT3119B/lt not_active IP Right Cessation
-
1993
- 1993-05-25 EC EC1993000933A patent/ECSP930933A/es unknown
-
1994
- 1994-06-02 BG BG98827A patent/BG98827A/xx unknown
- 1994-06-17 NO NO942303A patent/NO942303D0/no unknown
- 1994-06-17 FI FI942932A patent/FI942932A0/fi unknown
- 1994-08-10 EE EE9400117A patent/EE03015B1/xx unknown
-
1995
- 1995-06-16 HU HU95P/P00218P patent/HU211478A9/hu unknown
Also Published As
Publication number | Publication date |
---|---|
RO115785B1 (ro) | 2000-06-30 |
ZA929883B (en) | 1994-05-16 |
SI9200404A (en) | 1993-06-30 |
BG98827A (en) | 1995-06-30 |
AU677170B2 (en) | 1997-04-17 |
PL172048B1 (pl) | 1997-07-31 |
PH31073A (en) | 1998-02-05 |
FI942932A (fi) | 1994-06-17 |
LT3119B (en) | 1994-12-27 |
MY111055A (en) | 1999-08-30 |
HU914060D0 (en) | 1992-03-30 |
BR9206950A (pt) | 1995-11-28 |
IL104150A (en) | 1997-11-20 |
HUT63579A (en) | 1993-09-28 |
CA2125776A1 (en) | 1993-07-08 |
LV10386B (en) | 1995-12-20 |
CZ147494A3 (en) | 1995-01-18 |
HU211478A9 (en) | 1995-11-28 |
FI942932A0 (fi) | 1994-06-17 |
AU3265293A (en) | 1993-07-28 |
EP0617615A1 (en) | 1994-10-05 |
US5589513A (en) | 1996-12-31 |
JPH07502730A (ja) | 1995-03-23 |
WO1993012775A1 (en) | 1993-07-08 |
LV10386A (lv) | 1995-02-20 |
NZ246384A (en) | 1996-02-27 |
SK74494A3 (en) | 1995-01-12 |
KR940703655A (ko) | 1994-12-12 |
LTIP249A (en) | 1994-07-15 |
NO942303D0 (no) | 1994-06-17 |
EE03015B1 (et) | 1997-08-15 |
ECSP930933A (es) | 1994-04-20 |
RU2125448C1 (ru) | 1999-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO942303L (hu) | ||
NO20051966L (no) | Nye pyrimidinamidderivater og anvendelse derav | |
NO932813D0 (no) | Peptider som er i stand til aa inhibere aktiviteten av hivprotease, deres fremstilling og deres terapeutiske anvendelse | |
NO963447L (no) | Transdermale, terapeutiske systemer som inneholder seksualsteroider | |
DK0951474T3 (da) | Nye cyclosporinderivater, deres fremstilling og farmaceutiske præparater deraf | |
DE59509751D1 (de) | Gegen hautalterung wirksame stoffe oder wirkstoffkombinationen und zubereitungen | |
DK1363608T3 (da) | Formuleringer omfattende ibuprofen og diphenhydramin og deres anvendelse til behandling af sovnforstyrrelser | |
DK0703786T3 (da) | Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS | |
NO985821L (no) | Substituerte syklopentanforbindelser som er nyttige som neuraminidaseinhibitorer | |
NO883229D0 (no) | Nye benzimidazolderivater, fremgangsmaate for deres fremstilling og farmasoeytisk preparat inneholdende slike derivater. | |
CY1106155T1 (el) | Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους | |
RU94031161A (ru) | Фармацевтическая композиция и способ ее получения, способ лечения нарушений, развивающихся вследствие нейродегенеративных процессов | |
DK498384A (da) | N-cycliske benzensulfonamider, fremgangsmaade til deres fremstilling og deres anvendelse som aktiv komponent i farmaceutiske kompositioner | |
ES2089286T3 (es) | Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos. | |
NO20023111L (no) | Utvortes preparat for behandling av pruritus | |
NO881778L (no) | Enkastiner: nye glykopeptider med enkefalinase-hemmende virkning. fremgangsmaate til deres fremstilling og deres anvendelse som farmasoeytiske preparater. | |
DE50113974D1 (de) | Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen | |
RS49520B (sr) | Antimikrobno aktivne smeše | |
AP9901474A0 (en) | Pharmaceutical composition for treating viral diseases. | |
DE59910944D1 (de) | Transdermales therapeutisches system zur anwendung von candesartan | |
NO970185L (no) | Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi | |
DK1232173T3 (da) | Nye fusidinsyrederivater | |
DK0480391T3 (da) | Emulgatorfrie emulsionspolymerer, deres fremstilling og deres anvendelse i farmaceutiske præparater med forlænget frigivelse af virksomt stof | |
DK0858345T3 (da) | Anvendelse af muteiner af vildtypecytokiner som immunogener | |
ES2032476T3 (es) | Un procedimiento para preparar nuevos derivados de 2-anilinotiazolina. |